Innovative Eyewear Inc Q2 2026: Revenue $1.01M, EPS $(0.26) — 10-Q Summary

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Innovative Eyewear Inc reported Q2 2026 results with revenue of $1.01M, a 74% YoY increase. The net loss narrowed to $1.67M from $2.11M in the prior year, and diluted EPS improved to $(0.26) from $(0.66). Growth was driven by strong unit volume and expanded wholesale/retail channels, supported by Reebok cobranded launches and Lucyd product updates.

Innovative Eyewear Inc reported second-quarter 2026 results with revenue rising to $1.01M and an improved net loss of $1.67M versus a $2.11M loss a year earlier; diluted loss per share narrowed to $0.26 from $0.66 in Q2 2025.

Financial Highlights

  • Revenue: $1.01M for Q2 2026, up from $579K in Q2 2025 (74% YoY).
  • Net income: Net loss $1.671M for Q2 2026, improved from net loss $2.106M in Q2 2025 (loss narrowed by $435K YoY).
  • Diluted EPS: Loss per share $0.26 for Q2 2026, versus loss per share $0.66 in Q2 2025 (improved YoY).

Business Highlights

  • Revenue growth was driven by strong unit volume, with revenues up 74% in the quarter and 73% year-to-date.
  • Channel mix shifted toward wholesale and retail as store count expanded and wholesale share increased versus the prior year.
  • Brand momentum from Reebok cobranded launches (sport line and April 2026 optical) and Lucyd Armor contributed to higher sales.
  • Product and software updates included the Reebok optical line, a white‑label offering, and Lucyd app upgrades adding ChatGPT/Claude integrations, Walkie functionality and translations.
  • Operational milestones: rollout with FYidoctors Canada covering 345 locations, a 50‑store U.S. retail test, and kiosks deployed in about 160 stores.

Original SEC Filing: Innovative Eyewear Inc [ LUCY ] - 10-Q - Aug. 14, 2026

Disclaimer

Source: TradingView The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.